wellrank.ai
Sign In

How much is Ozempic per month without insurance and how do people afford it?

ClaudepricingCollected Sep 15, 2026, 11:38 UTC

Verbatim response from Claude

Ozempic Cost Without Insurance

Retail price: approximately $900–$1,000+ per month for the standard doses (0.5mg or 1mg pens).


How People Afford It

Manufacturer Savings:

  • Novo Nordisk's savings card – eligible commercially insured patients may pay as little as $25/month, but this doesn't help the uninsured

Compounding Pharmacies (Popular Option):

  • Hims & Hers, Ro, Sesame – offer compounded semaglutide (same active ingredient) for roughly $150–$300/month
  • ⚠️ Note: FDA has raised safety concerns about compounded versions, and availability is changing as shortages resolve

Discount Programs:

  • GoodRx – can reduce cost to around $850–$950, so modest savings
  • NeedyMeds.org – helps find assistance programs
  • Novo Nordisk Patient Assistance Program – free or reduced cost for low-income, uninsured patients who qualify

Insurance Workarounds:

  • Some switch to Wegovy (same drug, different FDA indication) which some insurance plans cover for obesity

Telehealth Platforms:

  • Found, Calibrate, or Sequence bundle prescriptions with coaching and may have better pricing options

Bottom line: Most uninsured people rely on compounding pharmacies or manufacturer assistance programs to make it manageable.

Brands mentioned in this answer

More Ozempic answers

See all Ozempic rankings and answers →

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.